SU1061818A1 - Method of treatment of pustular psoriasis - Google Patents
Method of treatment of pustular psoriasis Download PDFInfo
- Publication number
- SU1061818A1 SU1061818A1 SU823470299A SU3470299A SU1061818A1 SU 1061818 A1 SU1061818 A1 SU 1061818A1 SU 823470299 A SU823470299 A SU 823470299A SU 3470299 A SU3470299 A SU 3470299A SU 1061818 A1 SU1061818 A1 SU 1061818A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- psoriasis
- suspension
- placenta
- pustular psoriasis
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
СПОСГОБ ЛЕЧЕНИЯ ПУСТУЛЕЗНОГО ПСОРИАЗА путем введени лекарственных средств, отличающийс тем, что, с целью сокращени сроков лечени , подкожно пациенту ввод т взвесь плаценты в количестве 4-5 инъекций с интервалом .5-7 дн.THE METHOD OF TREATING EMPTY PSORIASIS by administering drugs, characterized in that, in order to shorten the treatment time, a suspension of the placenta is administered subcutaneously to the patient in an amount of 4-5 injections with an interval of .5-7 days.
Description
О) 00 00 Изобретение относитс к области медицины, в частности к дерматологии и касаетс способов лечени пус туЯезного псориаза. Известен способ лечени пустулез ного псориаза путем введени лекарс венных средств, например декариса С Однако известный способ лечени псориаза предусматривает длительное врем госпитализации больныхj лечение длитс 1-2 мес., а последующа поддерживающа терапи до 1-1,5 лет и более. Целью изобретени вл етс сокращение сроков лечени . Эта цель достигаетс тем, что согласно способу лечени пустулезного псориаза путем введений лекарст венных средств, подкожно пациенту ввод т взвесь плаценты в количестве 4-5 инъекций с интервалом 5-7 дн. Пример 1, Больна Г., страдакада пустулезным псориазом несколько лет, получила амбулаторное лечение взвесью плаценты в количестве 4 инъекций с интервалами в 5 дн. Показатели спонтанного розеткообразовани нейтрофилов до лечени сос тавл ли 554 в 1 мл крови (при норме 1112+101), а после курса лечени взвесью плаценты - 1173. В результате лечени наступила стойка ремисси , продолжающа с б мес и нормализовались иммунологические показатели крови. Пример 2. Больна С. по поводу пустулезного псориаза со сниженными показател ми спонтанного poзJetкooбpaзoвaни нейтрофилов до 464 в 1 мл крови получила лечение взвесью плаценты в количестве 4 инъекций с интервалами в б дн, после чего патологический кожный процесс разрещнлс , а показатели спонтанных розеткообразующих нейтрофилов возросли до 1456 в 1 МП крови. Ремисси продолжалась 8 мес. Пример 3. Больной К.с пустулезным .псориазом получил лечение взвесью плаценты в количестве 5 инъекций с интервалом 6-7 .дн с хорошим клиническим эффектом. Спонтанные розеткообразующие нейтрофилы с 376 в 1 мл КРО.ВИ восстановились до 1057. Клиническа ремисси длилась 8 мес. В таблице представлена сравнительна характеристика длительности лечени больных постулезным псориазом с помощью декариса и взвеси плаценты npenapciT Продолжительность лечени , нед. Декарис Взвесь плёщенты Как видно из таблицы предлагавMbft препарат позвол ет сократить сроки лечени в 2-2,5 раза. Предлагаегмый способ может быть использован в поликлинических и клинических учреждени х дерматологического ПРОФИЛЯ.O) 00 00 The invention relates to the field of medicine, in particular to dermatology, and concerns methods of treating susceptible psoriasis. A known method of treating pustular psoriasis by administering drugs, for example, Decaris C. However, the known method of treating psoriasis provides for a long time of hospitalization for patients for 1-2 months, and subsequent maintenance therapy up to 1-1.5 years or more. The aim of the invention is to reduce the duration of treatment. This goal is achieved by the fact that according to the method of treating pustular psoriasis by injecting drugs, a suspension of the placenta is administered subcutaneously to the patient in the amount of 4-5 injections with an interval of 5-7 days. Example 1, Ill. G., suffering from pustular psoriasis for several years, received outpatient treatment with a suspension of the placenta in the amount of 4 injections at 5-day intervals. Indicators of spontaneous neutrophil rosette formation before treatment were 554 in 1 ml of blood (at a rate of 1112 + 101), and after a course of treatment with a suspension of the placenta, 1173. As a result of treatment, there was a stable remission lasting for months and the immunological parameters of the blood normalized. Example 2. Patient S. for pustular psoriasis with reduced rates of spontaneous growth of neutrophils up to 464 in 1 ml of blood received treatment with a suspension of placenta in the amount of 4 injections at intervals of 6 days, after which the pathological cutaneous process with resolvers and spontaneous reflectors were used. up to 1456 in 1 MP of blood. Remissi lasted 8 months. Example 3. Patient K. with pustular. Psoriasis received treatment with a suspension of the placenta in the amount of 5 injections with an interval of 6-7. Days with a good clinical effect. Spontaneous rosette neutrophils from 376 in 1 ml of KRO.VI recovered to 1057. Clinical remission lasted 8 months. The table presents a comparative description of the duration of treatment of patients with post-acute psoriasis with the help of decaris and placenta suspension. NpenapciT Duration of treatment, weeks. Dekaris Suspension of papaschenta As can be seen from the table offering Mbft, the drug reduces the treatment time by 2-2.5 times. The proposed method can be used in polyclinic and clinical institutions of dermatological profile.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU823470299A SU1061818A1 (en) | 1982-07-19 | 1982-07-19 | Method of treatment of pustular psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU823470299A SU1061818A1 (en) | 1982-07-19 | 1982-07-19 | Method of treatment of pustular psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1061818A1 true SU1061818A1 (en) | 1983-12-23 |
Family
ID=21022368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU823470299A SU1061818A1 (en) | 1982-07-19 | 1982-07-19 | Method of treatment of pustular psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1061818A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997048405A1 (en) * | 1996-06-21 | 1997-12-24 | Jury Evgenievich Belyaev | Semi-finished product for producing drug bases, bases obtained using the same and variants, and drugs obtained using these bases and variants |
| US6040187A (en) * | 1994-03-18 | 2000-03-21 | Ivan Nikolaevich Golovistikov | Method of determining the suppressor cell component of human immune status and a means for the realization thereof |
| WO2000050047A3 (en) * | 1999-02-22 | 2000-12-21 | Ct De Histoterapia Placentaria | Composition for the treatment of psoriasis |
-
1982
- 1982-07-19 SU SU823470299A patent/SU1061818A1/en active
Non-Patent Citations (1)
| Title |
|---|
| 1. Л пон А.О. Псориаз.-Республиканский сборник научных работ. 1980. с. 133-136. * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040187A (en) * | 1994-03-18 | 2000-03-21 | Ivan Nikolaevich Golovistikov | Method of determining the suppressor cell component of human immune status and a means for the realization thereof |
| WO1997048405A1 (en) * | 1996-06-21 | 1997-12-24 | Jury Evgenievich Belyaev | Semi-finished product for producing drug bases, bases obtained using the same and variants, and drugs obtained using these bases and variants |
| WO2000050047A3 (en) * | 1999-02-22 | 2000-12-21 | Ct De Histoterapia Placentaria | Composition for the treatment of psoriasis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Davies et al. | Treatment of Vincent's stomatitis with metronidazole | |
| US20050282903A1 (en) | Use of Treprostinil to treat neuropathic diabetic foot ulcers | |
| SU1061818A1 (en) | Method of treatment of pustular psoriasis | |
| Bluntschli, HJ*** & Goetz | The effect of a new sympathicolytic drug (dihydroergocornine) on the blood-pressure with special reference to hypertension | |
| COHEN et al. | Use of a calcium chelating agent (NaEDTA) in cardiac arrhythmias | |
| HT et al. | Treatment of iron deficiency with ferrous fumarate. Assessment by a statistically accurate method. | |
| US6566339B1 (en) | Pharmaceutical composition | |
| SU1076119A1 (en) | Method of treatment of insufficiency of uteroplacental blood circulation | |
| SHWAYRI et al. | Periodic Disease: Report of a Case of Recurrent Abdominal and Thoracic Pain with Synchronous Gross Hematuria | |
| US20070260088A1 (en) | Calcium Trifluoroacetate for Preparing Antiangiogenetic Medicaments | |
| SU1706624A1 (en) | Method for curing opiumism and morphinism | |
| SU1194418A1 (en) | Method of treatment of children having purulent destructive pneumonia | |
| US4062974A (en) | Method for treating drepanocytosis | |
| SU1445728A1 (en) | Method of treatment of hypertension | |
| RU1790944C (en) | Method of anti-leukosis cyclophosphamide activity enhancement | |
| SU1097333A1 (en) | Method of treatment of hypertension | |
| SU1268168A1 (en) | Method of treatment of destructive pulmonary tuberculosis | |
| RU1822775C (en) | Method for treatment of trigeminal nerve neuralgia | |
| SU1690782A1 (en) | Method for anesthesia application during surgery | |
| SU1291153A1 (en) | Method of treatment of neurologic disturbances caused by heavy craniocerebral trauma | |
| Duggan | The treatment of African trypanosomiasis | |
| SU1729510A1 (en) | Method of pathogenetic therapy in cows at mastitis | |
| SU1680188A1 (en) | Method for treating carpal tunnel syndrome | |
| Berrington et al. | Modified leptazol convulsive therapy | |
| SU1724250A1 (en) | Method for treatment of early toxicoses of pregnancy |